Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Chinese Patent Office
QuintilesIMS
Cerilliant
Healthtrust
Medtronic
Farmers Insurance
Boehringer Ingelheim

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018663

« Back to Dashboard

NDA 018663 describes CHYMODIACTIN, which is a drug marketed by Chart Medcl and is included in one NDA. Additional details are available on the CHYMODIACTIN profile page.

The generic ingredient in CHYMODIACTIN is chymopapain. Additional details are available on the chymopapain profile page.
Summary for 018663
Tradename:CHYMODIACTIN
Applicant:Chart Medcl
Ingredient:chymopapain
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Nov 10, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength4,000 UNITS/VIAL
Approval Date:Aug 21, 1984TE:RLD:No

Expired US Patents for NDA 018663

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chart Medcl CHYMODIACTIN chymopapain INJECTABLE;INJECTION 018663-001 Nov 10, 1982 ➤ Sign Up ➤ Sign Up
Chart Medcl CHYMODIACTIN chymopapain INJECTABLE;INJECTION 018663-002 Aug 21, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Baxter
Accenture
McKinsey
Julphar
Chubb
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.